Formic Ventures

Nanome Inc. is a software company based in North Hollywood, California, founded in 2015. It specializes in developing a collaborative extended reality (XR) platform aimed at enhancing scientific discovery. This platform enables scientists to explore and visualize complex molecular structures effectively, streamlining computational workflows at the molecular scale. By integrating virtual reality and blockchain technologies, Nanome facilitates immersive applications that support pattern recognition and efficient drug design processes. The company's solutions are particularly beneficial for professionals in the biopharma sector, as well as in industries such as food and beverage, material science, and education. Nanome's innovative approach not only accelerates molecular computations but also allows researchers to collaborate securely while protecting their intellectual property.

cheMastery Group Ltd. is a Glasgow‑based company founded in 2019 that develops laboratory automation technology for the chemical sector. Its systems streamline experimental workflows, enabling scientists to conduct research, development, and manufacturing more efficiently and reliably. By integrating robotics, software, and data management, the company builds the infrastructure that supports modern chemistry laboratories. The technology is designed to reduce manual handling, improve reproducibility, and accelerate the pace of discovery in natural science and engineering.

SonoThera is a biotechnology company focused on developing innovative genetic therapies using ultrasound technology. The company's mission is to create non-viral genetic medicines that address the root causes of human diseases. SonoThera specializes in ultrasound-guided nonviral gene therapy, aiming to provide effective treatments for conditions that currently have suboptimal or no available treatments. By leveraging this approach, SonoThera seeks to enhance the health and quality of life for millions of people worldwide.

Biogenesis is building the end-to-end platform for clinical research.

Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

Nanome Inc. is a software company based in North Hollywood, California, founded in 2015. It specializes in developing a collaborative extended reality (XR) platform aimed at enhancing scientific discovery. This platform enables scientists to explore and visualize complex molecular structures effectively, streamlining computational workflows at the molecular scale. By integrating virtual reality and blockchain technologies, Nanome facilitates immersive applications that support pattern recognition and efficient drug design processes. The company's solutions are particularly beneficial for professionals in the biopharma sector, as well as in industries such as food and beverage, material science, and education. Nanome's innovative approach not only accelerates molecular computations but also allows researchers to collaborate securely while protecting their intellectual property.

Solving cancer resistance.

Sampling Human is a biotechnology company that develops computational tools to measure and analyze complex single-cell and spatial omic data on an industrial scale. Their technology enables pre-symptomatic screening, personalized medicine, and drug discovery by translating vast amounts of genetic analysis data into practical applications in fields such as diagnostics and bioengineering.

Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

Aviron Ltd engages in the research and development of specific antiviral agents against chronic Hepatitis C Virus (HCV) infection. The company has strategic alliances with CHEMRAR Hi-Tech Center, Chemical Diversity Research Institute, and DRUGS TECHNOLOGY, Ltd. Aviron Ltd was founded in 2010 and is based in Moscow, Russian Federation.

Aviron Interactive is a fitness company that specializes in providing innovative workout equipment designed for home use. Their flagship product, a connected rowing machine, incorporates gamification features to enhance the user experience. The rowing machine offers short, high-intensity workouts and adjustable resistance settings that combine cardiovascular and strength training. Aviron's platform includes a wide variety of engaging content, including workout programs curated by experienced trainers, as well as interactive games and competitions, ensuring users remain motivated and engaged over time. Through these offerings, Aviron aims to transform traditional workout routines into dynamic and enjoyable fitness experiences.

Framework is a company focused on creating environmentally friendly consumer electronics, specifically designed for easy upgrades, customization, and repair. Their flagship product, the Framework Laptop 13, received widespread acclaim, including recognition as one of TIME's Best Inventions of 2021. In 2023, the company expanded its offerings with the Framework Laptop 16, a high-performance notebook that features deeply customizable inputs and modular, upgradeable graphics. Framework's approach emphasizes user empowerment by enabling consumers to modify and assemble their devices independently, thereby promoting sustainability and reducing electronic waste.

MultiOmic Health is a company focused on addressing metabolic syndrome-related diseases through AI-enabled drug discovery. It collaborates with healthcare providers to gather and analyze de-identified patient data and bio-samples. The company's MOHSAIC® platform integrates multi-omics analysis, computational systems biology modeling, and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies.

Xcell Biosciences, Inc. is a San Francisco-based life science company founded in 2012, specializing in innovative technologies for cancer research and immunotherapy. The company has developed proprietary systems that capture, grow, and analyze cancer cells directly from patient blood samples, allowing for precise control over primary cell phenotype and function. This technology enhances the development and production of cell therapies, providing scientists with advanced tools for cell maintenance, expansion, and optimization. By supporting various primary cell types, including immune, stem, and tumor cells, Xcell Biosciences aims to improve predictive therapy development and clinical outcomes for patients undergoing immunotherapy.

Aviron Interactive is a fitness company that specializes in providing innovative workout equipment designed for home use. Their flagship product, a connected rowing machine, incorporates gamification features to enhance the user experience. The rowing machine offers short, high-intensity workouts and adjustable resistance settings that combine cardiovascular and strength training. Aviron's platform includes a wide variety of engaging content, including workout programs curated by experienced trainers, as well as interactive games and competitions, ensuring users remain motivated and engaged over time. Through these offerings, Aviron aims to transform traditional workout routines into dynamic and enjoyable fitness experiences.

Framework is a company focused on creating environmentally friendly consumer electronics, specifically designed for easy upgrades, customization, and repair. Their flagship product, the Framework Laptop 13, received widespread acclaim, including recognition as one of TIME's Best Inventions of 2021. In 2023, the company expanded its offerings with the Framework Laptop 16, a high-performance notebook that features deeply customizable inputs and modular, upgradeable graphics. Framework's approach emphasizes user empowerment by enabling consumers to modify and assemble their devices independently, thereby promoting sustainability and reducing electronic waste.

MultiOmic Health is a company focused on addressing metabolic syndrome-related diseases through AI-enabled drug discovery. It collaborates with healthcare providers to gather and analyze de-identified patient data and bio-samples. The company's MOHSAIC® platform integrates multi-omics analysis, computational systems biology modeling, and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies.

Scribe Biosciences specializes in developing single-cell analysis tools for both clinical and research applications. The company utilizes Printed Droplet Microfluidics (PDM), a technology that allows for precise manipulation of fluids at the picoliter scale. This system employs fluorescence-activated microfluidic droplet sorting and a specialized substrate to handle individual cells and fluid samples with high throughput, enabling detailed studies in areas such as infectious diseases and cancer research.

Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

Nanome Inc. is a software company based in North Hollywood, California, founded in 2015. It specializes in developing a collaborative extended reality (XR) platform aimed at enhancing scientific discovery. This platform enables scientists to explore and visualize complex molecular structures effectively, streamlining computational workflows at the molecular scale. By integrating virtual reality and blockchain technologies, Nanome facilitates immersive applications that support pattern recognition and efficient drug design processes. The company's solutions are particularly beneficial for professionals in the biopharma sector, as well as in industries such as food and beverage, material science, and education. Nanome's innovative approach not only accelerates molecular computations but also allows researchers to collaborate securely while protecting their intellectual property.

Wambi is a healthcare technology company specializing in solutions that enhance the quality of care within hospital and healthcare settings. The company offers a recognition platform aimed at improving workforce management, promoting clinician dignity, and addressing clinician burnout. By implementing engagement strategies and utilizing healthcare SaaS, Wambi’s platform enables organizations to foster a more positive work environment for healthcare professionals while simultaneously improving the patient experience. Additionally, their real-time patient feedback system plays a crucial role in helping healthcare facilities track key performance indicators (KPIs) and engage effectively with patients. An online inquiry form is available on the company's website for interested parties.

Deep Longevity, Inc. is a biotechnology company focused on developing innovative solutions for aging and longevity. Founded in 2016 and based in Hong Kong, the company specializes in creating aging and longevity clocks tailored for preventative medicine organizations, health clubs, insurance companies, and aging centers. Its offerings include Longevity Cloud, a platform that hosts deep aging clocks, and Young.AI, a web and mobile application designed to support longevity initiatives. Deep Longevity also develops multifactorial tools known as deep aging clocks to measure biological age, alongside a recommendation engine aimed at suggesting longevity interventions. The company employs advanced AI techniques to harness various data types, including clinical blood tests and other biological metrics, to enhance the accuracy of biological age predictions.

Angion Biomedica Corp. is a clinical-stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics aimed at treating acute organ injuries and fibrotic diseases, particularly focusing on renal conditions. The company is advancing several product candidates, including BB3, which is undergoing phase 3 trials for delayed graft function following kidney transplants and phase 2 trials for acute kidney injury related to open-heart surgery. Another key candidate, ANG-3070, is an orally bioavailable fibrokinase inhibitor designed for chronic kidney disease and polycystic kidney disease. Additionally, Angion is exploring other compounds targeting renal disease and fibrosis, such as ANG-3586 and ANG-4021. Founded in 1998, Angion is headquartered in San Francisco, California, with research facilities in New York and clinical operations in Boston.

Volumetric, Inc. is an advanced biomaterials and biofabrication company based in Houston, Texas, established in 2014. It specializes in developing a 3D bioprinting platform designed to create vascularized human tissue, which can be utilized in various applications such as life sciences, drug discovery, and medical devices. The company offers bioprinters and bioinks that aim to facilitate innovations in biomaterials, cancer research, and the potential replacement of human organs. By focusing on creating materials embedded with living cells, Volumetric is at the forefront of integrating cutting-edge technology into healthcare solutions.

Underdog Pharmaceuticals, Inc. is a biotechnology company focused on developing regenerative medicine and direct interventions to address age-related diseases. Founded in 2019 and based in Mountain View, California, the company aims to target toxic forms of cholesterol with its innovative products. These treatments provide potential solutions for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Underdog Pharmaceuticals utilizes rationally designed molecules and novel derivatives of established compounds to create disease-modifying therapies, reflecting a new perspective on cardiovascular health influenced by the SENS Research Foundation. Through its research and product development, the company seeks to treat the underlying causes of age-related diseases rather than merely addressing their symptoms.

Gordian Biotechnology is a therapeutics company based in San Francisco, California, founded in 2018. It specializes in developing a unique screening platform aimed at enhancing the efficiency of gene therapy development for complex age-related diseases. The company's platform focuses on researching and creating therapeutic drugs that target premature aging in humans, with the goal of curing age-related conditions and improving skin health.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

Encellin Inc., established in 2016, is a biotechnology company based in San Francisco, California. It specializes in developing innovative thin-film cell encapsulation devices for cell-based therapeutics, aiming to improve the lives of patients with chronic diseases initially focusing on Type 1 diabetes. The company's technology enables encapsulated cells to function as smart molecular factories, providing potential therapeutic solutions.

Arctoris Limited is a biotechnology company based in Oxford, United Kingdom, with additional operations in Boston and Singapore. Founded in 2016, Arctoris has developed a unique automated drug discovery platform that combines advanced robotics and data science to enhance the efficiency of drug discovery programs. The platform enables researchers and biotech entrepreneurs to design and execute cellular and molecular biology experiments online, generating high-quality data from various biochemical and cell-based assays. By providing secure data storage, analysis, and visualization, Arctoris allows clients to make informed decisions with reliable and well-annotated data. The company's approach focuses on oncology and neurodegenerative diseases, actively pursuing drug discovery programs while also offering access to its platform for select partners in the biotech and pharmaceutical sectors. This data-driven strategy aims to increase the likelihood of success and accelerate the progression of new therapies toward clinical application.

Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.

Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in the fields of human aging and longevity. The company aims to develop a comprehensive ecosystem of assets that target aging, age-related diseases, and regenerative medicine. By leveraging advancements in scientific and medical research, Juvenescence seeks to create therapeutics that significantly extend both healthspan and lifespan. Their approach involves forming partnerships with leading scientists and research institutions, in-licensing compounds from academia and industry, and developing novel therapies based on a deep understanding of the biological mechanisms of aging. Juvenescence's initiatives also encompass therapeutic strategies aimed at promoting healthy aging, metabolic health, and brain health, with the ultimate goal of addressing the societal implications of an aging population.

ZERO specializes in AI-powered email management technology designed specifically for legal professionals. The company automates administrative tasks that often consume valuable time, enabling lawyers to concentrate on their core legal work. Utilizing proprietary machine learning and natural language processing algorithms, ZERO's solutions facilitate the predictive and automatic filing of emails into systems like iManage and NetDocuments. Additionally, the technology captures time spent on emails from mobile devices, generates draft time entry narratives, and detects potential misdirected emails in real-time. By offering these productivity-enhancing features, ZERO helps lawyers streamline their workflows and focus on the most pertinent information in their inboxes.

Bev is a mission-driven brand focused on redefining the landscape of the alcoholic beverage industry, particularly within traditionally male-dominated spaces. The company produces a range of dry canned wines crafted from quality grapes, offering a modern cocktail experience. Bev's products are characterized by bright aromatics, including flavors such as strawberry, raspberry, white peach, and watermelon, while maintaining low sugar and carbohydrate content. This approach allows consumers to enjoy flavorful wines in a convenient format, appealing to a contemporary audience seeking both quality and accessibility in their beverage choices.

Iron Ox, Inc. is an innovative company that specializes in developing robotics for crop harvesting and sustainable indoor farming systems. Founded in 2015 and headquartered in San Carlos, California, Iron Ox operates greenhouses in Gilroy, California, and Lockhart, Texas. The company utilizes a combination of robotics, plant science, and machine learning to cultivate fresh, pesticide-free produce, including various leafy greens and culinary herbs. Their flagship product, Angus, is an autonomous farm mobile robot designed to enhance agricultural efficiency. By focusing on sustainable practices, Iron Ox aims to minimize agriculture's environmental impact while improving the availability, quality, and flavor of its products for consumers.

Anduril Industries is a defense technology company that designs, develops, and deploys hardware and software to address national security challenges for the United States and its allies. It offers the Lattice Platform, an AI-based system that fuses real-time data from computer vision, machine learning, and mesh networking into a single autonomous operating picture; Sentry Tower, which integrates data across the electromagnetic spectrum; Ghost sUAS, an unmanned autonomous, man-portable drone capable of performing missions with limited human intervention; and Anvil sUAS, a precision kinetic intercept that autonomously navigates to counter potential drone threats with visual verification by a human operator. Founded in 2017, Anduril is based in Irvine, California, with additional offices in Orange County, California; Washington, D.C.; and Seattle, Washington.

Bolt is a company dedicated to enhancing e-commerce by providing a streamlined checkout experience. Founded in 2014 and headquartered in San Francisco, Bolt offers a platform that enables retailers to facilitate secure, one-click checkouts for their customers, eliminating the need for passwords or repeated personal information. This approach not only simplifies the purchasing process but also improves conversion rates and customer retention for businesses. A growing number of retailers, including well-known brands such as REVOLVE, Casper, Badgley Mischka, and Benefit Cosmetics, utilize Bolt's services to meet the demand for efficient and user-friendly online shopping experiences. By democratizing commerce, Bolt aims to strengthen the connection between retailers and their customers.

PreNav, Inc. specializes in developing automated systems for infrastructure inspection, utilizing advanced drone technology and machine learning. Founded in 2013 and headquartered in San Carlos, California, the company has created a platform that integrates commercial drones with ground-based guidance robots and sophisticated software for mission planning and data analysis. This technology enables the drones to navigate complex environments, such as cell towers, wind turbines, and bridges, with centimeter-level precision. PreNav's systems can inspect critical components, measure key features, and produce detailed 3D reconstructions of industrial assets. By automating the inspection process, the company offers a safer, faster, and more cost-effective alternative to traditional inspection methods that often rely on climbers and scaffolding. PreNav's expertise spans various fields, including computer vision, mechanical engineering, and aeronautics, positioning it as a leader in addressing fundamental robotics challenges.